Volume 86, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Pregnancy in sickle cell disease (SCD) patients is associated with increased risk of maternal and fetal mortality. This study determines pregnancy outcomes among women with SCD delivering at Korle-Bu Teaching Hospital, Accra, Ghana. Nine hundred sixty (960) medical records of pregnant women (131 HbSS, 112 HbSC, and 717 comparison group) from 2007 to 2008 were reviewed. The HbSS women were at increased risk of eclampsia (adjusted odds ratio [AOR] = 10.56, 95% confidence interval [CI] = 3.60–30.96, < 0.001), intrauterine growth restriction (AOR = 4.00, 95% CI = 1.38–11.64, = 0.011), and placenta previa (AOR = 22.03, 95% CI = 9.87–49.14, < 0.001) compared with the comparison group. The HbSC women had increased risk for intrauterine fetal death (AOR = 3.38, 95% CI = 1.15–9.96, = 0.027) and decreased risk of delivering low birth weight babies (AOR = 0.21, 95% CI = 0.06–0.73, = 0.014). Women with SCD in Ghana are at a greater risk of morbidity and mortality in pregnancy compared with women without hemoglobinopathies. Improved maternal and fetal outcomes in Ghanaian women with SCD can be achieved through effective intervention by health care providers with thorough knowledge about predisposing factors toward adverse outcomes.


Article metrics loading...

Loading full text...

Full text loading...



  1. Stuart MJ, Nagel RL, , 2004. Sickle-cell disease. Lancet 364: 13431360.[Crossref]
  2. Ngo C, Kayem G, Habibi A, Benachi A, Goffinet F, Galacteros F, Haddad B, , 2010. Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions. Eur J Obstet Gynecol Reprod Biol 152: 138142.[Crossref]
  3. Hassell K, , 2005. Pregnancy and sickle cell disease. Hematol Oncol Clin North Am 19: 903916.[Crossref]
  4. Koshy M, , 1995. Sickle cell disease and pregnancy. Blood Rev 9: 157164.[Crossref]
  5. Villers MS, Jamison MG, De Castro LM, James AH, , 2008. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol 199: 125.[Crossref]
  6. Afolabi BB, Iwuala NC, Iwuala IC, Ogedengbe OK, , 2009. Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: a case control study. J Obstet Gynaecol 29: 104106.[Crossref]
  7. Dare FO, Makinde OO, Faasuba OB, , 1992. The obstetric performance of sickle cell disease patients and homozygous hemoglobin C disease patients in Ile-Ife, Nigeria. Int J Gynaecol Obstet 37: 163168.[Crossref]
  8. El-Shafei MA, Dhaliwal JK, Sandhu AK, , 1992. Pregnancy in sickle cell disease in Bahrain. Br J Obstet Gynaecol 99: 101104.[Crossref]
  9. Poddar D, Maude GH, Plant MJ, Scorer H, Serjeant GR, , 1986. Pregnancy in Jamaican women with homozygous sickle cell disease. Fetal and maternal outcome. Br J Obstet Gynaecol 93: 727732.[Crossref]
  10. Koshy M, Chisum D, Burd L, Orlina A, How H, , 1991. Management of sickle cell anemia and pregnancy. J Clin Apher 6: 230233.[Crossref]
  11. Smith JA, Espeland M, Bellevue R, Bonds D, Brown AK, Koshy M, , 1996. Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease. Obstet Gynecol 87: 199204.[Crossref]
  12. Howard RJ, Tuck SM, Pearson TC, , 1995. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. Br J Obstet Gynaecol 102: 947951.[Crossref]
  13. Odum CU, Anorlu RI, Dim SI, Oyekan TO, , 2002. Pregnancy outcome in HbSS-sickle cell disease in Lagos, Nigeria. West Afr J Med 21: 1923.
  14. Omo-Aghoja IO, Okonofua FE, , 2007. Pregnancy outcome in women with sickle cell: a five year review. Niger Postgrad Med J 14: 151154.
  15. Sun PM, Wilburn W, Raynor BD, Jamieson D, , 2001. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol 184: 11271130.[Crossref]
  16. Al Jama FE, Gasem T, Burshaid S, Rahman J, Al Suleiman SA, Rahman MS, , 2009. Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, eastern Saudi Arabia. Arch Gynecol Obstet 280: 793797.[Crossref]
  17. Serjeant GR, Serjeant BE, Mason KP, Hambleton IR, Fisher C, Higgs DR, , 2009. The changing face of homozygous sickle cell disease: 102 patients over 60 years. Int J Lab Hematol 31: 585596.[Crossref]
  18. World Health Organization, 2008. Management of Haemoglobin Disorders. Report of a Joint WHO-TIF Meeting, Nicosia, Cyprus, 16–18 November 2007.
  19. Serjeant GR, Loy LL, Crowther M, Hambleton IR, Thame M, , 2004. Outcome of pregnancy in homozygous sickle cell disease. Obstet Gynecol 103: 12781285.[Crossref]
  20. Hendrickse JP, Watson-Williams EJ, Luzzatto L, Ajabor LN, , 1972. Pregnancy in homozygous sickle-cell anaemia. J Obstet Gynaecol Br Commonw 79: 396409.[Crossref]
  21. Ndugwa CM, , 1982. Pregnancy in sickle cell anaemia in Uganda (1971–1980). East Afr Med J 59: 320326.
  22. Barfield WD, Barradas DT, Manning SE, Kotelchuck M, Shapiro-Mendoza CK, , 2010. Sickle cell disease and pregnancy outcomes: women of African descent. Am J Prev Med 38: S542S549.[Crossref]
  23. Ocheni S, Onah HE, Ibegbulam OG, Eze MI, , 2007. Pregnancy outcomes in patients with sickle cell disease in Enugu, Nigeria. Niger J Med 16: 252255.
  24. Lu MC, Halfon N, , 2003. Racial and ethnic disparities in birth outcomes: a life-course perspective. Matern Child Health J 7: 1330.[Crossref]
  25. Nabukera SK, Wingate MS, Owen J, Salihu HM, Swaminathan S, Alexander GR, Kirby RS, , 2009. Racial disparities in perinatal outcomes and pregnancy spacing among women delaying initiation of childbearing. Matern Child Health J 13: 8189.[Crossref]
  26. Adam S, Jonassaint J, Kruger H, Kail M, Orringer EP, Eckman JR, Ashley-Koch A, Telen MJ, De Castro LM, , 2008. Surgical and obstetric outcomes in adults with sickle cell disease. Am J Med 121: 916921.[Crossref]
  27. Charache S, Niebyl JR, , 1985. Pregnancy in sickle cell disease. Clin Haematol 14: 729746.
  28. Seoud MA, Cantwell C, Nobles G, Levy DL, , 1994. Outcome of pregnancies complicated by sickle cell and sickle-C hemoglobinopathies. Am J Perinatol 11: 187191.[Crossref]
  29. Serjeant GR, , 1985. Treatment of sickle cell disease in early childhood in Jamaica. Am J Pediatr Hematol Oncol 7: 235239.[Crossref]
  30. Yu CK, Stasiowska E, Stephens A, Awogbade M, Davies A, , 2009. Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic. J Obstet Gynaecol 29: 512516.[Crossref]
  31. Thame M, Lewis J, Trotman H, Hambleton I, Serjeant G, , 2007. The mechanisms of low birth weight in infants of mothers with homozygous sickle cell disease. Pediatrics 120: e686e693.[Crossref]
  32. Allen LH, , 2000. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 71: 1280S1284S.
  33. Baker WF, Jr, 2000. Iron deficiency in pregnancy, obstetrics, and gynecology. Hematol Oncol Clin North Am 14: 10611077.[Crossref]
  34. Beard JL, , 2000. Effectiveness and strategies of iron supplementation during pregnancy. Am J Clin Nutr 71: 1288S1294S.
  35. Blot I, Diallo D, Tchernia G, , 1999. Iron deficiency in pregnancy: effects on the newborn. Curr Opin Hematol 6: 6570.[Crossref]
  36. Rao R, Georgieff MK, , 2002. Perinatal aspects of iron metabolism. Acta Paediatr Suppl 91: 124129.[Crossref]
  37. Scholl TO, Reilly T, , 2000. Anemia, iron and pregnancy outcome. J Nutr 130: 443S447S.
  38. Zhang Q, Ananth CV, Li Z, Smulian JC, , 2009. Maternal anaemia and preterm birth: a prospective cohort study. Int J Epidemiol 38: 13801389.[Crossref]
  39. Koshy M, Burd L, Wallace D, Moawad A, Baron J, , 1988. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. N Engl J Med 319: 14471452.[Crossref]
  40. Oteng-Ntim E, Chase AR, Howard J, Khazaezadeh N, Anionwu E, , 2008. Sickle cell disease in pregnancy. Obstetrics, Gynaecol Reprod Med 18: 272278.[Crossref]
  41. Cudihy D, Lee RV, , 2009. The pathophysiology of pre-eclampsia: current clinical concepts. J Obstet Gynaecol 29: 576582.[Crossref]
  42. Tuck SM, , 1982. Sickle-cell disease and pregnancy. Br J Hosp Med 28: 125127.
  43. Morris JS, Dunn DT, Poddar D, Serjeant GR, , 1994. Haematological risk factors for pregnancy outcome in Jamaican women with homozygous sickle cell disease. Br J Obstet Gynaecol 101: 770773.[Crossref]
  44. Anyaegbunam A, Langer O, Brustman L, Damus K, Halpert R, Merkatz IR, , 1988. The application of uterine and umbilical artery velocimetry to the antenatal supervision of pregnancies complicated by maternal sickle hemoglobinopathies. Am J Obstet Gynecol 159: 544547.[Crossref]
  45. Nagel RL, Fabry ME, Steinberg MH, , 2003. The paradox of hemoglobin SC disease. Blood Rev 17: 167178.[Crossref]
  46. Powars DR, Hiti A, Ramicone E, Johnson C, Chan L, , 2002. Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol 70: 206215.[Crossref]
  47. Serjeant GR, Hambleton I, Thame M, , 2005. Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth. BJOG 112: 13081314.[Crossref]

Data & Media loading...

  • Received : 08 Oct 2011
  • Accepted : 27 Dec 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error